Fundz

Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer

PRIVATENov 12, 2024

Position

Chief Financial Officer

Company

Eagle Pharmaceuticals

Christopher Krawtschuk
ckrawtschuk@eagleus.com
Woodcliff LakeBiotechnologyHealthcareHealth Care

Description

Eagle Pharmaceuticals, Inc. appointed Christopher Krawtschuk as Chief Financial Officer, effective November 11, 2024. Christopher Krawtschuk brings deep experience in the pharmaceutical sector, having served in senior finance roles in companies such as bluebird bio and Jubilant Pharma.

Quick answer

Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer (November 12, 2024). Eagle Pharmaceuticals is based in Woodcliff Lake, New Jersey, United States.

Who is the new Chief Financial Officer at Eagle Pharmaceuticals?
Eagle Pharmaceuticals named Christopher Krawtschuk Chief Financial Officer, announced November 12, 2024.
What did Eagle Pharmaceuticals announce on November 12, 2024?
Eagle Pharmaceuticals, Inc. appointed Christopher Krawtschuk as Chief Financial Officer, effective November 11, 2024. Christopher Krawtschuk brings deep experience in the pharmaceutical sector, having served in senior finance roles in companies such as bluebird bio and Jubilant Pharma.
What does Eagle Pharmaceuticals do?
Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise.
Where is Eagle Pharmaceuticals based?
Eagle Pharmaceuticals is based in Woodcliff Lake, New Jersey, United States.
Which similar companies made leadership changes around the same time?
Azora Therapeutics, Inc. (DE) (November 5, 2024), TransMedics Group (November 1, 2024), Treace (December 2, 2024) and Beam Therapeutics Inc. (December 6, 2024) also announced leadership changes within 45 days of Eagle Pharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Eagle Pharmaceuticals, and when

A new leader at Eagle Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Eagle Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Eagle Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Eagle Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Eagle Pharmaceuticals

Location

Woodcliff Lake, New Jersey, United States

About

Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include PEMFEXY®, RYANODEX®, BENDEKA®, BELRAPZO®, TREAKISYM® (Japan), and Byfavo® and Barhemsys® through its wholly owned subsidiary Acacia Pharma Inc. Eagle’s oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Eagle Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Christopher
Likely contact at this company
••••••••@••••••••

See Christopher's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Eagle Pharmaceuticals's next move

Learn about Strategic plan

Eagle Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.